Abbott Can't Escape Infringement Claims Over HIV Testing
Abbott Laboratories must face allegations that its HIV testing products infringe a patent covering a method for replicating HIV-specific DNA, an Illinois federal judge ruled Tuesday, finding Abbott failed to show...To view the full article, register now.
Already a subscriber? Click here to view full article